Evidence map›Paper›PMID 42893195›Full record

ArticleKidney medicine2026

ICD-Coded Versus Undiagnosed Acute Kidney Injury in the Atherosclerosis Risk in Communities (ARIC) Study.

Grace G von Oiste, Aditya Surapaneni, Carina M Flaherty, Insa M Schmidt, Kunihiro Matsushita, Josef Coresh, Wan-Jin Yeo, Morgan E Grams

Abstract read
In one paragraph

Article in Kidney medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Grace G von OisteDivision of Precision Medicine, New York University Grossman School of Medicine, New York, NY.
Aditya SurapaneniDivision of Precision Medicine, New York University Grossman School of Medicine, New York, NY.
Carina M FlahertyDivision of Precision Medicine, New York University Grossman School of Medicine, New York, NY.
Insa M SchmidtSection of Nephrology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA.
Kunihiro MatsushitaDepartment of Epidemiology, Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Josef CoreshOptimal Aging Institute, New York University Grossman School of Medicine, New York, NY.
Wan-Jin YeoDivision of Precision Medicine, New York University Grossman School of Medicine, New York, NY.
Morgan E GramsDivision of Precision Medicine, New York University Grossman School of Medicine, New York, NY.

Funding

ARIC Neurocognitive Study (ARIC-NCS) Renewal 2023-2028U01HL096812 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI JOSEF CORESH, THOMAS H MOSLEY · 2010 to 2026
$65.7M
THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - COORDINATING CENTER - TASK AREA B.2 AND B.375N92022D00001 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COUPER, DAVID · 2022 to 2025
$13.7M
ARIC Neurocognitive Study (ARIC-NCS) Renewal 2 of 5U01HL096917 · NHLBI · UNIVERSITY OF MISSISSIPPI MED CTR · PI MOSLEY, THOMAS H · 2010 to 2018
$11.9M
ARIC Neurocognitive Study (ARIC-NCS) Renewal UNC 4 of 5U01HL096899 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COUPER, DAVID J · 2010 to 2018
$7.5M
ARIC Neurocognitive Study (ARIC-NCS)U01HL096902 · NHLBI · UNIVERSITY OF MINNESOTA · PI LUTSEY, PAMELA L. · 2010 to 2018
$7.4M
ARIC Neurocognitive Study (ARIC-NCS) Renewal 4 of 5U01HL096814 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HUGHES, TIMOTHY M., WAGENKNECHT, LYNNE E · 2010 to 2018
$6.5M
Medication Use and Adverse Events in CKDR01DK115534 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Alexander R Chang, Morgan Erika Grams · 2018 to 2026
$5.7M
THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK ORDER 01, TASK AREA A75N92022D00003 · NHLBI · UNIVERSITY OF MINNESOTA · PI LUTSEY, PAMELA L. · 2022 to 2025
$5.1M
THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK ORDER 01, TASK AREA A75N92022D00005 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI WAGENKNECHT, LYNNE E · 2022 to 2025
$5.0M
THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK ORDER 01, TASK AREA A75N92022D00004 · NHLBI · UNIVERSITY OF MISSISSIPPI MED CTR · PI WINDHAM, BEVERLY GWEN · 2022 to 2025
$4.8M
THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK ORDER 01, TASK AREA A75N92022D00002 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI CORESH, JOSEF · 2022 to 2025
$4.7M
Integrative Omics, Chronic Kidney Disease, and Adverse Outcomes in Older AdultsR01DK124399 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI JOSEF CORESH, Morgan Erika Grams · 2020 to 2026
$3.6M
NHLBI NIH HHS 75N92022D00001NHLBI NIH HHS 75N92022D00002NHLBI NIH HHS 75N92022D00003NHLBI NIH HHS 75N92022D00004NHLBI NIH HHS 75N92022D00005NHLBI NIH HHS K24 HL155861NHLBI NIH HHS U01 HL096812NHLBI NIH HHS U01 HL096814NHLBI NIH HHS U01 HL096899NHLBI NIH HHS U01 HL096902NHLBI NIH HHS U01 HL096917NIDDK NIH HHS R01 DK115534NIDDK NIH HHS R01 DK124399
6 · The paper itself

Abstract

Rationale & Objective: Acute kidney injury (AKI) is common among older adults and associated with adverse outcomes, yet it often goes undiagnosed. We aimed to compare the prevalence of undiagnosed versus Study Design: Prospective cohort study. Setting & Participants: A total of 5,692 adults with proteomic and metabolomic profiling from the Atherosclerosis Risk in Communities study, excluding individuals with end-stage kidney disease at baseline (2011-2013). Exposures: AKI, defined as either ICD-coded or undiagnosed based on 3 abstracted levels of serum creatinine measured during hospitalizations. Outcomes: Incident coronary heart disease, heart failure, stroke, and all-cause mortality. Analytical Approach: ICD-coded AKI was compared with undiagnosed AKI across all hospitalizations. Risk factors for ICD-coded and undiagnosed AKI were assessed separately using Cox proportional hazards models from study visit to the first AKI encounter. Time-varying Cox models were used to evaluate the associations of ICD-coded and undiagnosed AKI with adverse outcomes. Results: ICD codes identified 51.4% of AKI defined based on changes in serum creatinine, with higher sensitivity for more severe stages and a specificity of 87.0%. Undiagnosed AKI was more common in women; otherwise, clinical risk factors for undiagnosed AKI were similar to those for ICD-coded AKI, as were proteomic and metabolomic risk factors. Both AKI groups were strongly associated with coronary heart disease, heart failure, stroke, and mortality. Limitations: AKI was estimated using 3 values of serum creatinine only and not urinary output. Diagnosed AKI was identified using billing codes, which may underestimate clinical diagnosis of AKI. Conclusions: Undiagnosed AKI is prevalent, especially among women, and is biologically and prognostically similar to ICD-coded AKI, motivating efforts to improve AKI recognition and diagnosis.

Indexed as

Acute kidney injuryepidemiologyInternational Classification of Diseasesmetabolomicsproteomics

Identifiers

PMID42893195
PMCPMC13676090

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.